Form 4 for DLB Dolby Laboratories, Inc.

Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0001209191-23-007896 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2023-02-08	2023-02-07	DLB	GOTCHER PETER C	Dir	A - Grant	$0.00	+3,296	40.7K	+9%	$0
	2023-02-08	2023-02-06	DLB	GOTCHER PETER C	Dir	S - Sale	$84.88	-6,288	37.4K	-14%	-$533.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2023-02-07	A	A	3,296	$0.00	40,720	D	—	—	(F2) Award represents a total of 3,296 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2024 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. (F3) Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest.
2	Common	Class A Common Stock	2023-02-06	S	D	6,288	$84.88	37,424	D	—	—	(F1) This transaction was executed in multiple trades at prices ranging from $84.75 to $85.445. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.